Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Akeso, Inc.

Equities

9926

KYG0146B1032

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:20 26/04/2024 BST 		5-day change 1st Jan Change
48.7 HKD +0.52% Intraday chart for Akeso, Inc. +10.93% +4.96%
04-24 Akeso’s Supplemental New Drug Application for Cervical Cancer Drug Accepted by Chinese Regulator MT
04-24 National Medical Products Administration Accepted the Supplemental New Drug Application by Akeso, Inc. for (Cadonilimab, Pd-1/Ctla-4) as First-Line Treatment for Cervical Cancer CI

Evolution of the average Target Price on Akeso, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1af9520e725f005b11cb3f5e81.mcE8q-bcy486yJv1ZpLGPvF91MtDRlA2-XEBj2YMIXk.9LVE6bWlhMtA__inS6r_SIMTtpQnCWBDgzVU_A04TkzAu3n9v5KG43mZ8A~2a5e790920420cc718edb33ca928a62a

Analyst Recommendations on Akeso, Inc.

Nomura Adjusts Akeso’s Price Target to HK$52.80 From HK$48.84, Keeps at Buy MT
Nomura Adjusts Akeso's Price Target to HK$48.84 From HK$50.14, Keeps at Buy MT
Nomura Adjusts Akeso's Price Target to HK$50.14 From HK$46.04, Keeps at Buy MT
Nomura Adjusts Akeso's Price Target to HK$46.04 From HK$31.54, Keeps at Buy MT
Nomura Adjusts Akeso's Price Target to HK$31.54 From HK$35.81, Keeps at Buy MT
UBS Adjusts Akeso’s Price Target to HK$26.68 From HK$29.60, Keeps at Buy MT
UBS Adjusts Akeso’s Price Target to HK$29.60 From HK$32.40, Keeps at Buy MT
Nomura Adjusts Akeso's Price Target to HK$35.81 From HK$53.66, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
45.08 CNY
Average target price
55.44 CNY
Spread / Average Target
+22.97%
High Price Target
63.52 CNY
Spread / Highest target
+40.92%
Low Price Target
45.74 CNY
Spread / Lowest Target
+1.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Akeso, Inc.

Nomura
UBS

Ratings for Akeso, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. Consensus Akeso, Inc.